Reuters logo
BRIEF-Aurobindo Pharma expects U.S. drug price erosion to continue for at least another 4 qtrs - exec
May 30, 2017 / 4:10 AM / 6 months ago

BRIEF-Aurobindo Pharma expects U.S. drug price erosion to continue for at least another 4 qtrs - exec

May 30 (Reuters) - Aurobindo Pharma Ltd

* Exec says expects U.S. drug price erosion to continue for at least another four quarters

* Exec says price erosion in U.S. here to stay; only the fittest, with a broad number of drug applications will survive. Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below